Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 15 posts of 200 posts found.

hiv_test

Rates of HIV rise amongst older population

September 28, 2017
Medical Communications HIV, HIV test, biotech, drugs, pharma, pharmaceutical

It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …

News

New therapy offers triple threat to HIV virus

September 22, 2017
Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

News

Anti-HIV drug PrEP proves safety in gay and bisexual adolescents

September 6, 2017
Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma

A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …

News
hiv_testing_kit

HIV home tests seized from market over potential risk

August 24, 2017
Sales and Marketing HIV, MHRA, biotech, drugs, pharma, pharmaceutical

The MHRA has removed over 100 HIV home testing kits from two UK based suppliers, after they were found not …

News
blood_test

HIV-screening by GPs could reduce incidence and cost

July 31, 2017
Sales and Marketing GP, HIV, NHS, biotech, drugs, pharma, pharmaceutical

Researchers have found that offering first-time patients a HIV test in an area of high-prevalence could help reduce levels of …

News
janssen_latest_logo_on_sign

Janssen single tablet regimen shows Phase 3 success in HIV

July 26, 2017
Research and Development HIV, Janssen, biotech, healthcare, pharma, pharmaceuticals

The latest Phase 3 data investigating Janssen’s darunivir in the treatment of human immunodeficiency virus (HIV-1) showed that the drug …

News

Monthly injectable HIV treatment proves as effective as traditional daily pill regimen

July 24, 2017
Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals

New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …

News
blood_bags

Contaminated blood inquiry to probe thousands of deaths

July 12, 2017
Medical Communications, Research and Development HCV, HIV, biotech, drugs, haemophilia, pharma, pharmaceutical

UK Government has announced that it will launch an inquiry to discover how 4,670 people were given blood infected by …

News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
needle-1291170_960_720

HIV cases in gay men fall for the first time in England

June 23, 2017
Medical Communications HIV, PrEP

For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was …

News
hiv

Inovio posts “exceptional” results for HIV vaccine

May 25, 2017
Research and Development AIDS, HIV, HIV vaccine, Vaccine

Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …

News
love4life_world_aids_day_foundation_stockholm_sweden_linda_rehlin

HIV life expectancy boosted 10 years by new drugs

May 11, 2017
Research and Development HIV

The latest research to emerge from authors of the University of Bristol has revealed that those living with HIV can …

News
mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

March 6, 2017
Sales and Marketing Cipla, HIV, India, Lopinavir

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …

News
vaccine

Cuba begins Phase 1 testing of HIV vaccine

February 27, 2017
Research and Development, Sales and Marketing Cuba, HIV

Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …

News
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025